250 related articles for article (PubMed ID: 19414151)
1. Pharmacogenetics in chemotherapy of colorectal cancer.
Henriette Tanja L; Guchelaar HJ; Gelderblom H
Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of colorectal cancer prevention and treatment.
Nguyen H; Tran A; Lipkin S; Fruehauf JP
Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients.
Cortejoso L; López-Fernández LA
Pharmacogenomics; 2012 Jul; 13(10):1173-91. PubMed ID: 22909207
[TBL] [Abstract][Full Text] [Related]
4. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C
Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493
[TBL] [Abstract][Full Text] [Related]
5. Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review).
Aiello M; Vella N; Cannavò C; Scalisi A; Spandidos DA; Toffoli G; Buonadonna A; Libra M; Stivala F
Mol Med Rep; 2011; 4(2):203-8. PubMed ID: 21468552
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics for individualized cancer chemotherapy.
Efferth T; Volm M
Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.
Kweekel DM; Gelderblom H; Guchelaar HJ
Cancer Treat Rev; 2005 Apr; 31(2):90-105. PubMed ID: 15847979
[TBL] [Abstract][Full Text] [Related]
8. Genetic factors influencing pyrimidine-antagonist chemotherapy.
Maring JG; Groen HJ; Wachters FM; Uges DR; de Vries EG
Pharmacogenomics J; 2005; 5(4):226-43. PubMed ID: 16041392
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacogenetics and tumor sensitivity of antineoplastic agents. Application to colorectal cancer].
Milano G
Rev Prat; 2008 May; 58(10):1056-9. PubMed ID: 18652401
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers of chemotherapeutic response and toxicity in colorectal cancer.
Braun MS; Quirke P; Seymour MT
Expert Rev Anticancer Ther; 2007 Apr; 7(4):489-501. PubMed ID: 17428170
[TBL] [Abstract][Full Text] [Related]
11. Cancer pharmacogenetics.
Marsh S
Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy.
Russo A; Corsale S; Cammareri P; Agnese V; Cascio S; Di Fede G; Macaluso M; Bazan V
J Cell Physiol; 2005 Sep; 204(3):742-9. PubMed ID: 15828025
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic application in personalized cancer treatment.
Kristyanto H; Utomo AR
Acta Med Indones; 2010 Apr; 42(2):109-15. PubMed ID: 20513938
[TBL] [Abstract][Full Text] [Related]
14. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
Mladosievicova B; Carter A; Kristova V
Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
[TBL] [Abstract][Full Text] [Related]
15. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
Wadhawan A; Stephens R; Adams R
Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics in gastrointestinal tumors.
Stöhlmacher J
Onkologie; 2005 Aug; 28(8-9):435-40. PubMed ID: 16160407
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
Hasegawa Y
Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics and biomarkers in colorectal cancer.
Strimpakos AS; Syrigos KN; Saif MW
Pharmacogenomics J; 2009 Jun; 9(3):147-60. PubMed ID: 19381163
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics in cancer treatment.
Nagasubramanian R; Innocenti F; Ratain MJ
Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
